Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide Stress Test to Predict Need for Renal Replacement Therapy in Ischemic Acute Tubular Necrosis in ICU
2017-004301-41Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of furosemide in acute tubular necrosis (ATN) and acute kidney failure (AKF), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2018; status: active.
02
Drugs
furosemide
03
Conditions
acute tubular necrosis (ATN)acute kidney failure (AKF)
Beyond the preview
Go deeper on 2017-004301-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004301-41.